Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-Iodine Sinus Rinse and Mouthwash for COVID-19
NCT04393792Phase 1Completed
- Sponsor
- Hampshire Hospitals NHS Foundation Trust
- Start
- May 2020
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 1, randomised trial of povidone-iodine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hampshire Hospitals NHS Foundation Trust. Primary endpoint: Change in viral load in the oral and nasopharyngeal cavity at Day 14. Started May 2020; status: completed.
02
Drugs
povidone-iodine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04393792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04393792.